For patients with homozygous haplotypes, haploidentical donors have no GVH mismatch.
Transplant outcomes were similar between hetero-to-homo and matched sibling HCT.
Incidences of acute GVHD and NRM were low after homo-to-homo transplantation.
Hetero-to-homo transplantation without T cell depletion is a viable option.